Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872322 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 7 Pages |
Abstract
Conclusions: Our data suggest that the level of Ku70 expression can be used as a molecular marker to predict the response to RT and the locoregional control after RT and concurrent chemotherapy in patients with nondisseminated NPC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sang-wook M.D., Kyung-Ja M.D., Jin-hong M.D., Sang Yoon M.D., Soon Yuhl M.D., Bong-Jae M.D., Sung-Bae M.D., Seung-Ho M.D., Jong Hoon M.D., Seung Do M.D., Seong Soo M.D., Eun Kyung M.D., Eunsil M.D.,